Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.

Source:http://linkedlifedata.com/resource/pubmed/id/17878220

Download in:

View as

General Info

PMID
17878220